Guided Therapeutics (GTHP) Net Cash Flow (2011 - 2025)
Guided Therapeutics recorded quarterly Net Cash Flow of -$24000.0 in Q4 2025, up 75.0% quarter-over-quarter from -$96000.0 in Q3 2025, and down 112.37% year-over-year from $194000.0 in Q4 2024.
Guided Therapeutics' Net Cash Flow history runs 15 years deep, the most recent figure standing at -$24000.0 for Q4 2025.
- In Q4 2025, Net Cash Flow fell 112.37% year-over-year to -$24000.0; the TTM figure through Dec 2025 stood at -$323000.0 (down 59.11% YoY), while the FY2025 annual figure was -$325000.0, down 60.1% from the prior year.
- Net Cash Flow came in at -$24000.0 for Q4 2025 at Guided Therapeutics, up from -$96000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $2.2 million in Q3 2022 to a low of -$627000.0 in Q3 2023.
- A 5-year average of -$5150.0 and a median of -$143000.0 in 2023 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow surged 690.03% in 2022 and tumbled 680.49% in 2023, its largest moves.
- Guided Therapeutics' Net Cash Flow stood at $102000.0 in 2021, then sank by 476.47% to -$384000.0 in 2022, then soared by 63.54% to -$140000.0 in 2023, then soared by 238.57% to $194000.0 in 2024, then slumped by 112.37% to -$24000.0 in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$24000.0, -$96000.0, and $70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | -627,000.00 |
| Sep 30, 2023 | -627,000.00 |
| Jun 30, 2023 | -479,000.00 |
| Jun 30, 2023 | -479,000.00 |
| Mar 31, 2023 | -476,000.00 |
| Mar 31, 2023 | -476,000.00 |
| Dec 31, 2022 | -384,000.00 |
| Dec 31, 2022 | -384,000.00 |
| Sep 30, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.25 Mn |
| Jun 30, 2022 | -262,000.00 |
| Jun 30, 2022 | -262,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Sep 30, 2021 | -381,000.00 |
| Sep 30, 2021 | -381,000.00 |
| Jun 30, 2021 | -325,000.00 |
| Jun 30, 2021 | -325,000.00 |
| Mar 31, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | -399,000.00 |
| Dec 31, 2020 | -399,000.00 |
| Sep 30, 2020 | -183,000.00 |
| Sep 30, 2020 | -183,000.00 |
| Jun 30, 2020 | 743,000.00 |
| Jun 30, 2020 | 743,000.00 |
| Mar 31, 2020 | -878,000.00 |
| Mar 31, 2020 | -878,000.00 |
| Dec 31, 2019 | 899,000.00 |
| Dec 31, 2019 | 899,000.00 |
| Jun 30, 2019 | -6,000.00 |
| Jun 30, 2019 | -6,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Dec 31, 2018 | -70,000.00 |
| Dec 31, 2018 | -70,000.00 |
| Sep 30, 2018 | 29,000.00 |
| Sep 30, 2018 | 29,000.00 |
| Jun 30, 2018 | -35,000.00 |
| Jun 30, 2018 | -35,000.00 |
| Mar 31, 2018 | 75,000.00 |
| Mar 31, 2018 | 75,000.00 |
| Dec 31, 2017 | -73,000.00 |
| Dec 31, 2017 | -73,000.00 |
| Sep 30, 2017 | 66,000.00 |
| Sep 30, 2017 | 66,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Mar 31, 2017 | -13,000.00 |
| Mar 31, 2017 | -13,000.00 |
| Dec 31, 2016 | 10,000.00 |
| Dec 31, 2016 | 10,000.00 |
| Sep 30, 2016 | 48,000.00 |
| Sep 30, 2016 | 48,000.00 |
| Jun 30, 2016 | 550,000.00 |
| Jun 30, 2016 | 550,000.00 |
| Mar 31, 2016 | 976,000.00 |
| Mar 31, 2016 | 976,000.00 |
| Dec 31, 2015 | 316,000.00 |
| Dec 31, 2015 | 316,000.00 |
| Sep 30, 2015 | 594,000.00 |
| Sep 30, 2015 | 594,000.00 |
| Jun 30, 2015 | 2.52 Mn |
| Jun 30, 2015 | 2.52 Mn |
| Mar 31, 2015 | 482,000.00 |
| Mar 31, 2015 | 482,000.00 |
| Dec 31, 2014 | 1.60 Mn |
| Dec 31, 2014 | 1.60 Mn |
| Sep 30, 2014 | 1.54 Mn |
| Sep 30, 2014 | 1.54 Mn |
| Jun 30, 2014 | 2.30 Mn |
| Jun 30, 2014 | 2.30 Mn |
| Mar 31, 2014 | 396,000.00 |
| Mar 31, 2014 | 396,000.00 |
| Dec 31, 2013 | 1.31 Mn |
| Dec 31, 2013 | 1.31 Mn |
| Sep 30, 2013 | 105,000.00 |
| Sep 30, 2013 | 105,000.00 |
| Jun 30, 2013 | 2.33 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 1.38 Mn |
| Mar 31, 2013 | 1.38 Mn |
| Dec 31, 2012 | -15,000.00 |
| Dec 31, 2012 | -15,000.00 |
| Sep 30, 2012 | 2.20 Mn |
| Sep 30, 2012 | 2.20 Mn |
| Jun 30, 2012 | 334,000.00 |
| Jun 30, 2012 | 334,000.00 |
| Mar 31, 2012 | -6,000.00 |
| Mar 31, 2012 | -6,000.00 |
| Dec 31, 2011 | 2.04 Mn |
| Dec 31, 2011 | 2.04 Mn |
| Sep 30, 2011 | -364,000.00 |
| Sep 30, 2011 | -364,000.00 |
| Jun 30, 2011 | -70,000.00 |
| Jun 30, 2011 | -70,000.00 |
| Mar 31, 2011 | 58,000.00 |
| Mar 31, 2011 | 58,000.00 |